Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

about

Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease

P2860

Q58700150-708481CB-6313-411E-8C5D-A966EACCD859

P2860

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

Item

http://www.wikidata.org/entity/Q36315311

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@ast

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@en

type

Item

label

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@ast

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@en

prefLabel

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@ast

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@en

P1476

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

@en

P2093

J Cridlig

http://www.w3.org/2001/XMLSchema#string

L Frimat

http://www.w3.org/2001/XMLSchema#string

N O Peters

http://www.w3.org/2001/XMLSchema#string

P2860

Considerations and challenges in defining optimal iron utilization in hemodialysis

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.

Ethics and observational studies in medical research: various rules in a common framework.

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.

Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.

Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge.

Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.

Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.

A randomized trial of intravenous and oral iron in chronic kidney disease

P2888

s12882-017-0513-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12882-017-0513-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Jay

Guy Rostoker

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084250426

http://www.w3.org/2001/XMLSchema#string

P698

28320343

http://www.w3.org/2001/XMLSchema#string

P932

5358046

http://www.w3.org/2001/XMLSchema#string

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

about

P2860

P2860

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932